CID 11237985

Naronapride

Structural Information

Molecular Formula
C27H41ClN4O5
SMILES
CO[C@H]1CN(CC[C@H]1NC(=O)C2=CC(=C(C=C2OC)N)Cl)CCCCCC(=O)O[C@H]3CN4CCC3CC4
InChI
InChI=1S/C27H41ClN4O5/c1-35-23-15-21(29)20(28)14-19(23)27(34)30-22-9-13-31(17-25(22)36-2)10-5-3-4-6-26(33)37-24-16-32-11-7-18(24)8-12-32/h14-15,18,22,24-25H,3-13,16-17,29H2,1-2H3,(H,30,34)/t22-,24+,25+/m1/s1
InChIKey
VGDDOIZXGFJDRC-VJTSUQJLSA-N
Compound name
[(3R)-1-azabicyclo[2.2.2]octan-3-yl] 6-[(3S,4R)-4-[(4-amino-5-chloro-2-methoxybenzoyl)amino]-3-methoxypiperidin-1-yl]hexanoate
Related CIDs

2D Structure

compound 2d structure
3
Annotation Hits

5
References

265
Patents

536.27655 Da
Monoisotopic Mass

2.8
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 537.28383 220.4
[M+Na]+ 559.26577 227.2
[M+NH4]+ 554.31037 225.9
[M+K]+ 575.23971 220.9
[M-H]- 535.26927 220.1
[M+Na-2H]- 557.25122 215.8
[M]+ 536.27600 221.0
[M]- 536.27710 221.0
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe